Sign in
Taking people in South AfricaNo phase

Tests brief counseling to help pregnant and postpartum women keep taking HIV prevention pills

Tests brief counseling for depression and trauma in pregnant women taking HIV prevention pills.

Key facts

Who runs it
Boston University Charles River Campus
Where
Cape Town, South AfricaSee the siteAlso in 1 other country, 1 site
Trial code
Registry title
Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa
Status
Recruiting
People taking part
118 people, planned
Started
17 Apr 2025
Expected to end
30 Jul 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Brief CBT-Based Intervention
  • Enhanced Treatment as Usual
Record updated
17 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women who are HIV-negative, had trouble taking or recently started PrEP, and have posttraumatic stress or depression symptoms. It tests a short counselling programme.

Age
15 years and older
Sex
Female only
Disease stage
Pregnant, attending antenatal care at the Gugulethu MOU. Moderate to severe posttraumatic stress and/or depression symptoms (PCL-5 score of ≥31 and/or EPDS score of ≥13; cutoffs may be adjusted by 3-5 points).
Earlier treatment
Started PrEP recently (<1 month ago) or has trouble taking PrEP, either documented (>2 weeks late to pick up a PrEP refill) or self-reported.
Biomarker or test result
HIV-negative

Main reasons for not taking part

  • Cannot give informed consent or assent in English or Xhosa
  • Significant mental illness that could interfere, such as active psychosis or untreated bipolar disorder
  • Health conditions that make it hard to travel to the clinic

This trial only enrols pregnant participants. The registry sentence this rests on: Pregnant and presenting antenatal care at the Gugulethu MOU

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • For participants across all three aims are:; Female sex; Aged 15+; Pregnant and presenting antenatal care at the Gugulethu MOU; HIV-negative; Recent PrEP initiation (<1 month ago) or PrEP adherence challenges, either documented (>2 weeks late to pick up PrEP refill) or self-reported; Moderate to severe symptoms of posttraumatic stress and/or depression (defined as a score of ≥31 on PTSD Checklist for DSM-5 (PCL-5) and/or a score of ≥13 on the Edinburgh Postnatal Depression Scale (EPDS). Cutoff scores may be adjusted by 3-5 points to facilitate recruitment

Who cannot take part

  • There are no exclusion criteria with respect to parity or gravidity; Participants who are unable to provide informed consent or assent in English or Xhosa; Have a significant psychiatric illness (e.g., active psychotic disorder or untreated bipolar disorder) that could interfere with participation will be excluded. Positive symptoms of active psychosis or mania will be assessed by the research assistants. They will be trained to identify delusions, hallucinations, disorganized or pressured speech, flight of ideas, and grandiosity as they speak to potential participants; Potential participants will also be asked if they have any health conditions that make it difficult for them to travel to the clinic

This trial is currently available in South Africa.

Also in 1 other country, 1 site

  • Gugulethu Midwife Obstetric Unit (MOU)Cape Town, South AfricaContact: Lucia Knight, PhDTaking people

About the trial

What the trial wants to find out

Pregnant women in South Africa (SA) are at high risk of HIV acquisition. Pre-exposure prophylaxis (PrEP) use during pregnancy is both safe and effective in preventing HIV. However, posttraumatic stress (associated with intimate partner violence and/or other traumas) and depression negatively impact PrEP adherence among women in SA. Addressing posttraumatic stress and depression will likely improve PrEP adherence and persistence (i.e., sustained PrEP adherence over time) during pregnancy and breastfeeding, which are periods of dramatically increased HIV risk. The overarching goal of this proposal is to develop and test the feasibility and acceptability of a cognitive behavioral intervention that targets common underlying factors of posttraumatic stress and depression to improve PrEP adherence and persistence during pregnancy and the postpartum transition. The specific aims of the project are to (1) explore the mechanisms by which posttraumatic stress and depression impact PrEP adherence and persistence during pregnancy via qualitative interviews; (2) develop a brief PrEP adherence and persistence intervention (~4 sessions) that reduces the negative impact of psychological mechanisms common to posttraumatic stress and depression on PrEP use, and builds behavioral skills to improve self-care; and (3) evaluate the feasibility, acceptability, and signals of preliminary efficacy of the intervention, which will be integrated into antenatal care, in a pilot randomized controlled trial. All data will be collected in the Midwife Obstetrics Unit (MOU) in Gugulethu, a peri-urban settlement and former township community outside of Cape Town, SA.

The 2 groups in the trial

  • Treatment Condition: Brief CBT-Based InterventionTreatment being tested

    This group (n=30) will be guided through an adaptation of Life Steps, a single-session, cognitive behavioral therapy (CBT)-based medication adherence intervention that has been used to increase PrEP adherence. Participants will also receive four additional intervention sessions.

    Treatment: Brief CBT-Based Intervention

  • Control Condition: Enhanced Treatment as UsualExisting treatment, for comparison

    Participants randomized to the control condition (n= 30) will receive enhanced treated as usual.

    Treatment: Enhanced Treatment as Usual

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa
Plain-language title
Tests brief counseling to help pregnant and postpartum women keep taking HIV prevention pillsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
17 July 2026